Ad is loading...
BOLD
Price
$3.01
Change
-$0.23 (-7.10%)
Updated
Nov 15 closing price
KOD
Price
$5.53
Change
+$0.23 (+4.34%)
Updated
Nov 15 closing price
130 days until earnings call
Ad is loading...

BOLD vs KOD

Header iconBOLD vs KOD Comparison
Open Charts BOLD vs KODBanner chart's image
Boundless Bio
Price$3.01
Change-$0.23 (-7.10%)
Volume$112.08K
CapitalizationN/A
Kodiak Sciences
Price$5.53
Change+$0.23 (+4.34%)
Volume$596.87K
CapitalizationN/A
BOLD vs KOD Comparison Chart
Loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BOLD vs. KOD commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Sell and KOD is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BOLD: $3.01 vs. KOD: $5.53)
Brand notoriety: BOLD and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 177% vs. KOD: 217%
Market capitalization -- BOLD: $67.12M vs. KOD: $290.96M
BOLD [@Biotechnology] is valued at $67.12M. KOD’s [@Biotechnology] market capitalization is $290.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileKOD’s FA Score has 1 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • KOD’s FA Score: 1 green, 4 red.
According to our system of comparison, KOD is a better buy in the long-term than BOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 4 TA indicator(s) are bullish while KOD’s TA Score has 3 bullish TA indicator(s).

  • BOLD’s TA Score: 4 bullish, 6 bearish.
  • KOD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, KOD is a better buy in the short-term than BOLD.

Price Growth

BOLD (@Biotechnology) experienced а -14.00% price change this week, while KOD (@Biotechnology) price change was +12.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BOLD is expected to report earnings on Nov 08, 2024.

KOD is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($291M) has a higher market cap than BOLD($67.1M). BOLD has higher annual earnings (EBITDA): -64.01M vs. KOD (-170.71M). KOD has more cash in the bank: 219M vs. BOLD (179M). BOLD has less debt than KOD: BOLD (837K) vs KOD (75.8M). BOLD (0) and KOD (0) have equivalent revenues.
BOLDKODBOLD / KOD
Capitalization67.1M291M23%
EBITDA-64.01M-170.71M37%
Gain YTDN/A81.908-
P/E RatioN/AN/A-
Revenue00-
Total Cash179M219M82%
Total Debt837K75.8M1%
FUNDAMENTALS RATINGS
KOD: Fundamental Ratings
KOD
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLDKOD
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 6 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 25 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDDVX15.89-0.08
-0.50%
Janus Henderson Responsible Intl Div D
WFGGX27.80-0.34
-1.21%
First Trust WCM Focused Global Gr Inv
SUSLX14.91-0.22
-1.45%
Lazard US Sustainable Equity Open
TILGX29.39-0.71
-2.36%
Nuveen Large Cap Growth R6
DRGTX87.43-2.21
-2.47%
Virtus Zevenbergen Technology Inst

BOLD and

Correlation & Price change

A.I.dvisor tells us that BOLD and ETXPF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLD and ETXPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
-7.10%
ETXPF - BOLD
32%
Poorly correlated
N/A
KOD - BOLD
32%
Poorly correlated
+4.34%
TNXP - BOLD
32%
Poorly correlated
-6.36%
GRI - BOLD
25%
Poorly correlated
-19.57%
AKBA - BOLD
25%
Poorly correlated
-3.76%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with CRSP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+4.34%
CRSP - KOD
44%
Loosely correlated
+0.85%
ABCL - KOD
42%
Loosely correlated
-3.99%
RXRX - KOD
42%
Loosely correlated
-10.64%
MGTX - KOD
41%
Loosely correlated
-2.41%
AVIR - KOD
41%
Loosely correlated
-2.72%
More